Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Strategies for Hepatocellular Carcinoma—A Multidisciplinary Approach
Isabella Lurje, Zoltán Czigány, Jan Bednarsch, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1465-1465
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 73
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
Isabella Lurje, Nadine T. Gaisa, Ralf Weiskirchen, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101191-101191
Closed Access | Times Cited: 69
Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study
Ouided Benslama, Sabrina Lekmine, Hamza Moussa, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 53-53
Open Access | Times Cited: 2
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu, Shenshen Yang, Kailong Wang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 120, pp. 109543-109543
Open Access | Times Cited: 144
Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma
Oluwaseun Adebayo Bamodu, Hang-Lung Chang, Jiann-Ruey Ong, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 746-746
Open Access | Times Cited: 115
Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications
Zoltán Czigány, Isabella Lurje, Moritz Schmelzle, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 846-846
Open Access | Times Cited: 100
Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
Isabella Lurje, Linda Hammerich, Frank Tacke
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7378-7378
Open Access | Times Cited: 93
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
Alireza Tojjari, Ahmed Saeed, Meghana Singh, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1357-1357
Open Access | Times Cited: 28
Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma
Zhanbo Sun, Lixian Liu, Hongyuan Liang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 4, pp. 577-588
Closed Access | Times Cited: 11
Knockdown of liver cancer cell‐secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling
Shujie Xie, Xiang Li, Yan Jia, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma
Abdullah Altaf, Yutaka Endo, Muhammad Musaab Munir, et al.
HPB (2024) Vol. 26, Iss. 8, pp. 1040-1050
Closed Access | Times Cited: 9
Radiogenomics and Radiomics in Liver Cancers
Aman Saini, Ilana Breen, Yash Pershad, et al.
Diagnostics (2018) Vol. 9, Iss. 1, pp. 4-4
Open Access | Times Cited: 65
Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis
Francisco Tustumi, Lucas Ernani, Fabrício Ferreira Coelho, et al.
HPB (2018) Vol. 20, Iss. 12, pp. 1109-1118
Open Access | Times Cited: 60
The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
Zhentian Xu, Haiyang Xie, Lin Zhou, et al.
Analytical Cellular Pathology (2019) Vol. 2019, pp. 1-7
Open Access | Times Cited: 57
Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare
Xiaotao Zhang, Hashem B. El–Serag, Aaron P. Thrift
Cancer Causes & Control (2021) Vol. 32, Iss. 4, pp. 317-325
Closed Access | Times Cited: 50
In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
Isabella Lurje, Wiebke Werner, Raphael Mohr, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort
F. Meister, Georg Lurje, Suekran Verhoeven, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 720-720
Open Access | Times Cited: 33
LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
Qing Wei, Guoman Liu, Zihua Huang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1019-1035
Open Access | Times Cited: 19
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Suresh Kalathil, Yasmin Thanavala
Cells (2021) Vol. 10, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 39
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation
Zoltán Czigány, Wiebke Kramp, Isabella Lurje, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 2, pp. 358-367
Open Access | Times Cited: 37
“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Astha Malik, Unmesha Thanekar, Surya Amarachintha, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 37
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
Surendra Pal Chaudhary, Stephanie Reyes, Matthew Chase, et al.
The Oncologist (2023) Vol. 28, Iss. 4, pp. 341-350
Open Access | Times Cited: 16
CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients
Simon Bernatz, Oleg Elenberger, Jörg Ackermann, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Artificial Intelligence in Liver Diseases: Recent Advances
Feifei Lu, Meng Yao, Xiaoting Song, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 967-990
Closed Access | Times Cited: 5
Predicting Ki-67 expression in hepatocellular carcinoma: nomogram based on clinical factors and contrast-enhanced ultrasound radiomics signatures
Di Zhang, Xian‐Ya Zhang, Wenwu Lu, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 5, pp. 1419-1431
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top